Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Expert Review of Vaccines|March 25, 2016
Progress, challenges, and opportunities in Francisella vaccine developmentKaren L Elkins, Sherry L Kurtz, Roberto De Pascalis
Infection and Immunity|June 25, 2008
Diverse myeloid and lymphoid cell subpopulations produce gamma interferon during early innate immune responses to Francisella tularensis live vaccine strainRoberto De Pascalis, Betsy C Taylor, Karen L Elkins
Plos One|March 27, 2023
IL-12p40 is essential but not sufficient for Francisella tularensis LVS clearance in chronically infected miceLara R Mittereder, Jonathan Swoboda, Roberto De Pascalis, et al.
Infection and Immunity|January 27, 2016
Activities of Murine Peripheral Blood Lymphocytes Provide Immune Correlates That Predict Francisella tularensis Vaccine EfficacyRoberto De Pascalis, Lara Mittereder, Nikki J Kennett, et al.
Methods (San Diego, Calif.)|April 26, 2005
SDR grafting--a new approach to antibody humanizationSyed V S Kashmiri, Roberto De Pascalis, Noreen R Gonzales, et al.
Plos One|March 24, 2021
Deficiency in CCR2 increases susceptibility of mice to infection with an intracellular pathogen, Francisella tularensis LVS, but does not impair development of protective immunitySherry L Kurtz, Roberto De Pascalis, Anda I Meierovics, et al.
Microbes and Infection|November 11, 2008
NK cells activated in vivo by bacterial DNA control the intracellular growth of Francisella tularensis LVSKaren L Elkins, Susan M Colombini, Arthur M Krieg, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 3, 2005
Minimizing the immunogenicity of antibodies for clinical applicationNoreen R Gonzales, Roberto De Pascalis, Jeffrey Schlom, et al.
Microbes and Infection|August 1, 2016
GM-CSF has disparate roles during intranasal and intradermal Francisella tularensis infectionSherry L Kurtz, Catharine M Bosio, Roberto De Pascalis, et al.
Mbio|February 9, 2024
Visualization of immune pathways that enhance the neutralizing antibody response to vaccines after primary immunizationAnita Verma, Roberto De Pascalis, Christopher P Mocca, et al.
Pageof 3